Mangalore Refinery And Petrochemicals Ltd Q4 FY26 Earnings Analysis

Published 1 Jun 2026 | Petroleum Products | Market Cap: ₹26.3K Cr

Price

145

Market Cap

₹26.3K Cr

P/E Ratio

13.7

Revenue Rank

Rank 3

Margin Rank

Rank 3

Earnings Summary

- MRPL targets significant growth in retail outlets, from 200 currently to 500 in 3 years, and 1,000 in 5 years, aiming for retail to become a major revenue source. - MRPL expects retail expansion to be a major growth driver, targeting 500 retail outlets in 3 years and 1,000 outlets in 5 years, which will enhance stable and superior margins compared to export sales.

📊 Revenue & Sales Performance

Rank 3

- MRPL targets significant growth in retail outlets, from 200 currently to 500 in 3 years, and 1,000 in 5 years, aiming for retail to become a major revenue source. - Retail margins are superior and provide stability compared to volatile export sales. - Expansion includes developing depots and pipeline infrastructure across southern India and adjoining states, with investments in Mumbai, Vizag, Kerala, and Bangalore airport pipeline projects. - Marketing investment in depots and pipelines expected around ₹500 crore in the near future. - Retail currently contributes about 1.5-2% of sales; with 1,000 outlets, marketing sales are expected to gain substantial revenue. - Refining throughput was about 18 MMT (120% of nameplate capacity), with capex around ₹1,500 crore annually to maintain and expand operations. - Long-term plans include becoming a full-fledged refining and marketing company with accelerated growth post initial retail rollout.

📈 Profitability & Margins

Rank 3

- MRPL expects retail expansion to be a major growth driver, targeting 500 retail outlets in 3 years and 1,000 outlets in 5 years, which will enhance stable and superior margins compared to export sales. - The Isobutyl Benzene (IBB) pilot project is underway but commercialization and profitability impact are several years away; IRR assessment will be clearer post-technical inspection and licensing (3-4 years timeline). - Capex guidance is around ₹1,500 crores annually for maintenance, revamps, and modest capacity additions, expected to stay in similar range for FY27. - Bio-ATF plant will help with compliance and supply of blended aviation fuel starting 2027, likely contributing positively. - The company aims to maintain throughput above nameplate capacity (~120%) and reduce fuel loss with grid power projects, improving operational efficiency. - Potential for dividend payout exists depending on Q4 performance and overall profitability.

🏗️ Capital Expenditure Plans

Yes

- FY26 Capex guidance is around ₹1,500 crores, similar to FY25, focusing on revamping and maintenance to keep the plant running at peak performance. - Approximately ₹400-450 crores of FY26 capex will go towards growth projects such as retail outlets, grid power import, and pipeline rerouting; the rest is maintenance. - Ongoing projects include the Isobutyl Benzene (IBB) pilot plant and infrastructure enhancements like the Bangalore airport pipeline. - Plans to expand retail outlets from 200 currently to 250 by fiscal year-end, 500 in 3 years, and 1,000 in 5 years, aiming for retail to be a major revenue stream. - Investing in depots and pipeline infrastructure, targeting Mumbai, Vizag, Kerala, and southern India with an annual investment of approximately ₹500 crores. - Bio-ATF plant under construction at a cost of ₹364 crores for CORSIA compliance, starting supply from 2027. - Dividend payout subject to board decision considering capex, debt, and profitability.

💰 Fundraising & Capital Structure

No information

- No explicit mention of new fundraising through equity in the provided transcript. - Current debt status: Rs. 9,290 crores with debt-equity ratio at 0.63. - MRPL has Non-Convertible Debentures (NCDs) worth Rs. 3,260 crores and External Commercial Borrowings (ECBs) of $500 million (~Rs. 4,500 crores). - No major NCDs due until 2028, providing debt stability. - The company is actively evaluating ECBs given forex market conditions, balancing between debt reduction and foreign exchange losses. - Planned capital expenditure (Capex) is around Rs. 1,500 crores per annum, funded through internal accruals and existing debt. - Dividend consideration depends on Capex needs, debt position, and profitability; potential dividend after Q4 subject to board approval. - No specific plans or announcements for raising new debt or equity in near term.

📋 Order Book & Pipeline

No information

The provided pages from the document "1996.pdf" do not mention any details regarding the current or expected order book or pending orders for MRPL. The discussion primarily revolves around: - Capex plans (around INR 1,500 crores annually) - Status and financial expectations related to the Isobutyl Benzene (IBB) pilot project. - Retail outlet expansions. - Debt numbers and financial metrics. - Freight rates, crude sourcing, refinery costs, and export percentages. No specific information about order books or pending orders is provided in the available excerpts.

Key Metrics

Revenue

Rank 3

Margin

Rank 3

Capex

Yes

Fundraise

No information

Order Book

No information

Frequently Asked Questions

What were Mangalore Refinery And Petrochemicals Ltd Q4 FY26 results?

- MRPL targets significant growth in retail outlets, from 200 currently to 500 in 3 years, and 1,000 in 5 years, aiming for retail to become a major revenue source. - MRPL expects retail expansion to be a major growth driver, targeting 500 retail outlets in 3 years and 1,000 outlets in 5 years, which will enhance stable and superior margins compared to export sales.

What is Mangalore Refinery And Petrochemicals Ltd share price analysis?

Mangalore Refinery And Petrochemicals Ltd currently shows a below-average growth signal. The stock trades at a P/E of 13.7 with a market cap of ₹26,345. Investors should review the full earnings analysis for detailed insights.

Is Mangalore Refinery And Petrochemicals Ltd planning capital expenditure?

- FY26 Capex guidance is around ₹1,500 crores, similar to FY25, focusing on revamping and maintenance to keep the plant running at peak performance.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.